Vanda Pharmaceuticals
VNDA
$4.75
Share price
2.79%
Change (1 day)
-22.65%
Change (1 year)
Categories
Vanda Pharmaceuticals (VNDA) Fails to deliver data
Key failure to deliver metrics for Vanda Pharmaceuticals:
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $0.01 M
- Last 3 months FTD volume: $0.07 M
- Last year FTD volume: $1.68 M
Failures to deliver for Vanda Pharmaceuticals (VNDA) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Vanda Pharmaceuticals (VNDA) - since 2013
Volume in USD (price x number of shares), data since 2013Vanda Pharmaceuticals (VNDA) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.05 M | -97.36% |
| 2023 | $1.98 M | 25.12% |
| 2022 | $1.58 M | -83.12% |
| 2021 | $9.37 M | 250.19% |
| 2020 | $2.67 M | 10.49% |
| 2019 | $2.42 M | -79.15% |
| 2018 | $11.62 M | 291.09% |
| 2017 | $2.97 M | -11.3% |
| 2016 | $3.34 M | -92.37% |
| 2015 | $43.92 M | 14.93% |
| 2014 | $38.22 M | 381.32% |
| 2013 | $7.94 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $0.14 B | $0.60 B | 🇺🇸 USA |
 Novartis NVS | $30.53 M | $95.22 M | 🇨🇭 Switzerland |
 Pfizer PFE | $31.87 M | $0.32 B | 🇺🇸 USA |
 Eli Lilly LLY | $50.92 M | $0.12 B | 🇺🇸 USA |
 Merck MRK | $8.48 M | $0.18 B | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $0.19 B | $0.29 B | 🇺🇸 USA |
 Titan Pharmaceuticals
TTNP | $0.02 M | $0.13 M | 🇺🇸 USA |